Updated Date: Mon, 03 Jan 2022 00:00:00 EST
JPM 2022: Bristol Myers plots 3 blockbuster launches to counter Revlimid’s patent cliff esagonowsky Mon, 01/10/2022 – 14:27
Six of President Joe Biden’s former covid-19 advisers have urged the president to take a different approach to […]
What you need to knowOverall survival of babies born extremely preterm has improved in recent years, but evidence […]
Complaints against doctors that arise in the current climate must be viewed in the “extraordinary” context of huge […]
The UK has seen a flurry of activity recently in relation to illegal drugs. The government published its […]
The government has sent 200 armed forces personnel into NHS hospitals across London to help ease staff shortages […]
JPM 2022: New Johnson & Johnson CEO Duato points out 5 pipeline meds that can generate $5B+ esagonowsky […]
JPM 2022: Vertex’s Trikafta holds the line as company lays groundwork for gene editing launch fkansteiner Mon, 01/10/2022 […]
Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use in U.S., Europe fkansteiner Mon, 01/10/2022 – 08:42